Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Diabetes and Vascular Disease Research
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Espinosa-Larrañaga, F.
Right arrow Articles by Medina-Santillán, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Espinosa-Larrañaga, F.
Right arrow Articles by Medina-Santillán, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NICOTINIC ACID
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The importance of low serum levels of high-density lipoprotein cholesterol (HDL-C) as a cardiovascular risk factor

Francisco Espinosa-Larrañaga

Master in Medical Sciences, Internal Medicine Private Practice, Clinic on Cardio-Metabolic Disease. Titular Professor in Clinic Medicine. Superior School Medicine. Polytechnic National Institute of Mexico

Margarita Vejar-Jalaf

Internal Medicine, Cardiology Section, Hospital Del Salvador, Santiago de Chile. Assistant Professor of Internal Medicine, Faculty of Medicine, University of Chile. Fellow European Society of Cardiology

Roberto Medina-Santillán

Titular Professor of Biochemistry, Superior Medical School, Polytechnic National Institute. Titular Professor, Postgraduate Division, Superior Medical School, Polytechnic National Institute. International Affairs Coordinator, National Academy of Medicine

In order to discuss and establish a joint position on the treatment of low serum levels of high-density lipoprotein cholesterol (HDL-C), a group of experts involved in the care of people with dyslipidaemia and at risk of cardiovascular disease met in Miami, Florida, US, on 5th and 6th March 2005. The experts came from the Latin American countries Argentina, Brazil, Chile, Colombia, Ecuador, Guatemala, Mexico and Venezuela and had at least five years of experience in the care of patients with dyslipidaemia and low HDL-C.

The main objective of the meeting was to discuss and propose a treatment for low serum HDL-C levels as a cardiovascular risk factor in patients and to create a group of useful recommendations in this regard, applicable to the daily clinical practice of physicians dealing with patients with dyslipidaemia and cardiovascular disease.

This document describes the methodology developed to obtain these recommendations and presents the results of this academic meeting.

Diabetes and Vascular Disease Research, Vol. 2, No. 1 Suppl, S1-S8 (2005)
DOI: 10.3132/dvdr.2005.016
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?